Seattle Clinical Research Center (SCRC) is a dedicated clinical trial investigative site. SCRC has successfully executed hundreds of multi-specialty Phase I-IV medical device and biopharma clinical trials since 1991 and has particular expertise in women’s health-related drugs and medical devices as well as migraine and vaccine studies.
About Our TransitionUnder the new ownership of Eric Hayashi, Seattle Women’s will become the new entity, Seattle Clinical Research Center. This partnership will allow our site and our sister site, Rainer Clinical Research Center, to come together under one organization. Through leadership of Dr. Robin Kroll and Eric Hayashi, Seattle CRC will look to expand their medical expertise beyond just Women’s Health and Diabetes research. With a combined nearly 60 years of experience behind the helm, Seattle CRC strives to provide excellence in all aspects of medical research.
For more information, read more here.